“Atorvastatin Suppresses Lipopolysaccharideinduced Inflammation in Human Coronary Artery Endothelial Cells”. 2022. Brazilian Journal of Pharmaceutical Sciences 58 (April). https://doi.org/10.1590/s2175-979020200001181092.